Published July 1, 2021 | Version major
Journal article Open

Bioink: a 3D-bioprinting tool for anticancer drug discovery and cancer management

Description

‘Bioinks’ are important tools for the fabrication of artificial living-tissue constructs that are able to mimic all properties of native tissues via 3D bioprinting technologies. Bioinks are most commonly made by incorporating live cells of interest within a natural or synthetic biocompatible polymeric matrix. In oncology research, the ability to recreate a tumor microenvironment (TME) using by 3D bioprinting constitutes a promising approach for drug development, screening, and in vitro cancer modeling. Here, we review the different types of bioink used for 3D bioprinting, with a focus on its application in cancer management. In addition, we consider the fabrication of bioink using customized materials/cells and their properties in the field of cancer drug discovery.

Files

2021_Bioink_Drug Discovery Today.pdf

Files (3.6 MB)

Name Size Download all
md5:46776d48732cf96ac7d2c11be4c3b94a
3.6 MB Preview Download

Additional details

Related works

Is cited by
Journal article: 10.1016/j.drudis.2021.03.010 (DOI)

Funding

SUPERBRAIN – Magneto-Plasmonic, Raman active Nanocapsules for Superior Pediatric Brain Cancer Therapy 840964
European Commission